<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>EPSILONNET</provider_name><provider_url>https://epsilonnet.gr/en/</provider_url><title>PharOS</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="kRrwuQP0BA"&gt;&lt;a href="https://epsilonnet.gr/en/case-study-page/pharos/"&gt;PharOS&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://epsilonnet.gr/en/case-study-page/pharos/embed/#?secret=kRrwuQP0BA" width="600" height="338" title="&#x201C;PharOS&#x201D; &#x2014; EPSILONNET" data-secret="kRrwuQP0BA" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://epsilonnet.gr/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://epsilonnet.gr/wp-content/uploads/2023/04/case-study-pharos.jpg</thumbnail_url><thumbnail_width>870</thumbnail_width><thumbnail_height>680</thumbnail_height><description>PharOS is a private pharmaceuticals company, producing and supplying generic drugs, offering added value services at the same time. The company has over 68 products in its portfolio and over 6,540 marketing authorizations globally. PharOS is an interdisciplinary organization, acknowledging the specialized and varied know-how required for correct development, approval and final promotion of a [&hellip;]</description></oembed>
